Different mutational characteristics of TSG in cell lines and surgical specimens.
Ontology highlight
ABSTRACT: One of the most crucial concerns of cancer research pertains to the differences between the neoplastic cells in tumor specimens in vivo and their counterparts in cell lines. The huge amount of results deposited in cancer genetic databases allows to address this issue from a wider perspective. Our analysis of the Sanger Institute Catalog Of Somatic Mutations In Cancer (COSMIC) database v61 showed a lower percentage of homozygous mutations in a group of tumor suppressor genes in surgical samples (in vivo) in comparison to their frequency in cell lines (in vitro). Similarly, the mutations resulting in the lack of protein (e.g., nonsense mutations or whole gene deletions) of several tumor suppressor genes (TSGs) were more frequently observed in vitro than in vivo. In this article, we suggest t
SUBMITTER: Stoczynska-Fidelus E
PROVIDER: S-EPMC4244698 | biostudies-literature | 2014 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA